Publications by authors named "F J Monteon"
Background: Tumoral calcinosis is an autosomal recessive disorder characterized by ectopic calcification and hyperphosphatemia.
Methods: We describe a family with tumoral calcinosis requiring amputations. The predominant metabolic anomaly identified in three affected family members was hyperphosphatemia.
Introduction: In Mexico, CAPD survival has been analyzed in few studies from the center of the country. However, there are concerns that such results may not represent what occurs in other province centers of our country, particularly in our geographical area.
Aim: To evaluate the patient and technique survival on CAPD of a single center of the west of Mexico, and compare them with other reported series.
An international collaborative study of 45 transplant centers was undertaken at the 14th International HLA (human leukocyte antigen) and Immunogenetics Workshop to see if HLA antibodies detected posttransplant are predictive of chronic graft failure. With the newly developed assay, MICA (major histocompatibility complex class I-related chain A) antibodies were also measured and their effect analyzed. Total of 5219 sera from patients who were more than 6 months posttransplant with functioning graft were tested for HLA antibodies by enzyme-linked immunosorbent assay, flow cytometry, or Luminex.
View Article and Find Full Text PDFArticle Synopsis
- Drug-related hepatotoxicity is prevalent among renal transplant recipients with chronic liver disease due to impaired drug metabolism.
- A case study of a 26-year-old male, who has survived 30 years post-renal transplant, highlights the risks of medications like azathioprine and pravastatin leading to liver damage.
- The importance of cautious use and monitoring of hepatotoxic drugs in these patients is emphasized, especially those with chronic hepatitis C virus infections.
Background And Aim: To what extent the serum levels of alanine aminotransferase (ALT) are related to histological characteristics of liver damage caused by hepatitis C virus (HCV) infection among patients with end-stage renal disease (ESRD) remains unclear.
Methods: Patients with a positive anti-HCV antibody titer confirmed by supplemental tests were evaluated by liver biopsy. We compared ALT levels in patients with and without renal damage, with similar histological grades and stages of inflammation and fibrosis.